Technical Analysis for OMGA - Omega Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 2.34 | -2.09% | -0.05 |
OMGA closed down 0.42 percent on Monday, April 22, 2024, on 48 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 2
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | -2.09% | |
| Down 3 Days in a Row | Weakness | -2.09% | |
| Oversold Stochastic | Weakness | -2.09% | |
| Narrow Range Bar | Range Contraction | -2.50% | |
| Wide Bands | Range Expansion | -2.50% | |
| Oversold Stochastic | Weakness | -2.50% | |
| Wide Bands | Range Expansion | -3.31% | |
| Oversold Stochastic | Weakness | -3.31% | |
| Slingshot Bearish | Bearish Swing Setup | -8.41% | |
| Bullish Engulfing | Bullish | -8.41% |
| Alert | Time |
|---|---|
| Down 2 % | 13 minutes ago |
| 60 Minute Opening Range Breakdown | 22 minutes ago |
| Outside Day | 22 minutes ago |
| Fell Below Previous Day's Low | 22 minutes ago |
| Down 1% | 22 minutes ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
Omega Therapeutics, Inc., a biotechnology company, develops genomic medicines to cure diseases. The company focuses on precision tuning to activate the human genome's native capacity to treat and cure diseases. It engages in designing, engineering, and manufacturing Epigenomic Controllers to target the GenomStats for the cell types of interest, with the ability to downregulate or upregulate genomic activity for therapeutic effect. Omega Therapeutics, Inc. was formerly known as VL42, Inc. and changed its name to Omega Therapeutics, Inc. in July 2017. The company was incorporated in 2016 and is based in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Disease Human Genome
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Disease Human Genome
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 10.08 |
| 52 Week Low | 1.3 |
| Average Volume | 403,438 |
| 200-Day Moving Average | 3.22 |
| 50-Day Moving Average | 3.50 |
| 20-Day Moving Average | 2.93 |
| 10-Day Moving Average | 2.64 |
| Average True Range | 0.22 |
| RSI (14) | 31.03 |
| ADX | 28.53 |
| +DI | 17.19 |
| -DI | 34.26 |
| Chandelier Exit (Long, 3 ATRs) | 3.10 |
| Chandelier Exit (Short, 3 ATRs) | 2.93 |
| Upper Bollinger Bands | 3.69 |
| Lower Bollinger Band | 2.16 |
| Percent B (%b) | 0.15 |
| BandWidth | 52.57 |
| MACD Line | -0.32 |
| MACD Signal Line | -0.28 |
| MACD Histogram | -0.0406 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.58 | ||||
| Resistance 3 (R3) | 2.60 | 2.55 | 2.55 | ||
| Resistance 2 (R2) | 2.55 | 2.50 | 2.54 | 2.54 | |
| Resistance 1 (R1) | 2.47 | 2.47 | 2.45 | 2.45 | 2.53 |
| Pivot Point | 2.43 | 2.43 | 2.41 | 2.42 | 2.43 |
| Support 1 (S1) | 2.35 | 2.38 | 2.32 | 2.33 | 2.25 |
| Support 2 (S2) | 2.30 | 2.35 | 2.29 | 2.24 | |
| Support 3 (S3) | 2.22 | 2.30 | 2.23 | ||
| Support 4 (S4) | 2.20 |
